Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortive Corporation stock logo
FTV
Fortive
$48.42
+2.5%
$60.27
$46.35
$83.32
$15.98B1.084.08 million shs8.11 million shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$0.75
+1.2%
$0.75
$0.66
$3.09
$93.59M1.42163,148 shs817,855 shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$7.98
+2.0%
$8.24
$3.09
$11.99
$101.48M0.1548,788 shs7,765 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$466.61
+0.0%
$423.62
$385.46
$627.88
$176.18B0.743.34 million shs1.98 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortive Corporation stock logo
FTV
Fortive
+2.48%-4.79%-8.66%-28.85%-28.44%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
+1.21%+0.55%-8.76%+7.16%-66.81%
Prenetics Global Limited stock logo
PRE
Prenetics Global
+2.05%-0.37%-0.68%+53.49%+45.09%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.17%-3.34%+8.96%+14.42%-21.98%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fortive Corporation stock logo
FTV
Fortive
4.8097 of 5 stars
4.23.01.72.51.92.52.5
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
3.3244 of 5 stars
2.55.00.00.03.44.20.6
Prenetics Global Limited stock logo
PRE
Prenetics Global
2.4183 of 5 stars
2.55.00.00.02.80.01.3
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4.9919 of 5 stars
4.45.02.54.14.12.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fortive Corporation stock logo
FTV
Fortive
2.33
Hold$65.8636.01% Upside
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
1.00
Sell$2.13183.33% Upside
Prenetics Global Limited stock logo
PRE
Prenetics Global
3.00
Buy$9.0012.78% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.71
Moderate Buy$593.0027.09% Upside

Current Analyst Ratings Breakdown

Latest FTV, PRE, TMO, and NAUT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2025
Fortive Corporation stock logo
FTV
Fortive
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$58.00 ➝ $56.00
7/31/2025
Fortive Corporation stock logo
FTV
Fortive
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$60.00 ➝ $55.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$460.00 ➝ $500.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$525.00 ➝ $535.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$570.00 ➝ $565.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$510.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$450.00 ➝ $490.00
7/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$553.00 ➝ $567.00
7/22/2025
Fortive Corporation stock logo
FTV
Fortive
Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/22/2025
Fortive Corporation stock logo
FTV
Fortive
Melius
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$62.00
(Data available from 8/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fortive Corporation stock logo
FTV
Fortive
$6.23B2.63$5.66 per share8.55$30.71 per share1.58
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.43 per shareN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
$30.62M3.38N/AN/A$13.20 per share0.60
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$42.88B4.11$30.05 per share15.53$133.67 per share3.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fortive Corporation stock logo
FTV
Fortive
$832.90M$2.2221.8111.052.9913.62%11.96%7.08%N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$70.78M-$0.52N/AN/AN/AN/A-32.53%-27.85%N/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%10/6/2025 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.34B$17.2926.9918.262.4915.24%16.82%8.38%10/22/2025 (Estimated)

Latest FTV, PRE, TMO, and NAUT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14-$0.12+$0.02-$0.12N/AN/A
7/30/2025Q2 2025
Fortive Corporation stock logo
FTV
Fortive
$0.60$0.58-$0.02$0.49$1.54 billion$1.52 billion
7/23/2025Q2 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.22$5.36+$0.14$4.28$10.68 billion$10.86 billion
6/12/2025Q1 2025
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A-$0.80N/A-$0.80N/A$17.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fortive Corporation stock logo
FTV
Fortive
$0.320.66%N/A14.41%2 Years
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.720.37%N/A9.95%8 Years

Latest FTV, PRE, TMO, and NAUT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.4%9/15/20259/15/202510/15/2025
5/21/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.43%6/13/20256/13/20257/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fortive Corporation stock logo
FTV
Fortive
0.28
0.98
0.82
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
18.52
18.52
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
2.07
1.89
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.65
1.93
1.50

Institutional Ownership

CompanyInstitutional Ownership
Fortive Corporation stock logo
FTV
Fortive
94.94%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Prenetics Global Limited stock logo
PRE
Prenetics Global
25.01%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Fortive Corporation stock logo
FTV
Fortive
0.92%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
41.10%
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fortive Corporation stock logo
FTV
Fortive
18,000338.34 million335.22 millionOptionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130126.31 million74.30 millionOptionable
Prenetics Global Limited stock logo
PRE
Prenetics Global
112.98 millionN/ANot Optionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000377.61 million376.25 millionOptionable

Recent News About These Companies

Promising Biotech Stocks To Follow Now - August 4th
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory
Thermo Fisher Scientific (NYSE:TMO) Raised to Buy at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Fortive stock logo

Fortive NYSE:FTV

$48.42 +1.20 (+2.54%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$48.58 +0.16 (+0.34%)
As of 08/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$0.75 +0.01 (+1.21%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$0.77 +0.02 (+2.67%)
As of 08/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Prenetics Global stock logo

Prenetics Global NASDAQ:PRE

$7.98 +0.16 (+2.05%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$7.89 -0.09 (-1.13%)
As of 08/5/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$466.61 +0.04 (+0.01%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$462.47 -4.14 (-0.89%)
As of 08/5/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.